Similar articles

• Data from clinical trials.

  Catanzaro LM, Morse GD. Catanzaro LM, et al. J Acquir Immune Defic Syndr. 2005 Mar;38 Suppl 1:S26-9. doi: 10.1097/01.qai.0000167036.48772.c8. J Acquir Immune Defic Syndr. 2005. PMID: 15867609 Review. No abstract available.
• Population-based study evaluating association between selected antiretroviral therapies and potential oral contraceptive failure.

  Clark RA, Theall K. Clark RA, et al. J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1219-20. doi: 10.1097/01.qai.0000136724.15758.ae. J Acquir Immune Defic Syndr. 2004. PMID: 15319685 No abstract available.
• Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.

  Price TM, Dupuis RE, Carr BR, Stanczyk FZ, Lobo RA, Droegemueller W. Price TM, et al. Am J Obstet Gynecol. 1993 May;168(5):1400-6. doi: 10.1016/s0002-9378(11)90772-8. Am J Obstet Gynecol. 1993. PMID: 8498419 Clinical Trial.
• Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.

  Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I. Bergink W, et al. Am J Obstet Gynecol. 1990 Dec;163(6 Pt 2):2132-7. doi: 10.1016/0002-9378(90)90553-j. Am J Obstet Gynecol. 1990. PMID: 2147817
• Interactions with hormonal contraception.

  Elliman A. Elliman A. Br J Fam Plann. 2000 Apr;26(2):109-11, quiz 111,122. doi: 10.1783/147118900101194193. Br J Fam Plann. 2000. PMID: 10896460 Review. No abstract available.